Survival in multiple myeloma has improved significantly with the advent of novel, more potent immunotherapies, including CAR ...

IVIG prophylaxis led to improvements in infection-free survival as well as progression free and overall survival in patients ...

Including 24-hour urine testing in multiple myeloma response assessments is largely unnecessary, a new phase 3 trial suggests ...

Treatment for multiple myeloma has evolved significantly, with long-term survival increasingly within reach for many patients ...

Bispecific antibodies show strong initial uptake in community settings for multiple myeloma treatment, particularly among ...

A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...

A high-fiber, plant-based diet delays progression to multiple myeloma, improves microbiome health, reduces inflammation, and ...

GSK’s cancer drug failed a confirmatory trial two years after an accelerated approval, but impressive new survival data could ...

Ciltacabtagene autoleucel achieved a 100% complete response rate in patients with high-risk smoldering multiple myeloma, as ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition ...

The data reported at ASH revealed a 74% OS rate in the Blenrep plus BorDex (BVd) arm of DREAMM-7 versus a 60% rate with ...